Update on Fusidic Acid (CEM-102) Tested against Neisseria gonorrhoeae and Chlamydia trachomatisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-10-0110OAAI
In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52010-03-0140OAAI
In vitro models of acute and long-term continuous infection of human respiratory epithelial cells with Chlamydophila pneumoniae have opposing effects on host cell apoptosisMICROBIAL PATHOGENESISIF3.52008-01-014PREAI
Isolation and antimicrobial susceptibilities of chlamydial isolates from western barred bandicootsJOURNAL OF CLINICAL MICROBIOLOGYIF5.42007-02-0116OAAI
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-03-0149OAAI
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52004-09-0111OAAI
In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52003-04-0125OAAI
In vitro activities of rifamycin derivatives ABI-1648 (rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52003-03-0127OAAI
In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52002-02-0122OAAI
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection modelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52002-02-0163OAAI
Ultrastructural study of Chlamydia pneumoniae in a continuous-infection modelJOURNAL OF CLINICAL MICROBIOLOGYIF5.42001-10-0150OAAI
Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosisANNALS OF NEUROLOGYIF7.72001-03-1515PREAI
Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?JOURNAL OF CLINICAL MICROBIOLOGYIF5.42000-11-0146OA
Is there an association between Kawasaki disease and Chlamydia pneumoniae?JOURNAL OF INFECTIOUS DISEASESIF4.52000-06-0116OAAI
Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52000-05-0121OAAI
In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52000-04-0137OAAI
In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.51999-11-0124OAAI
In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.61999-10-0113OAAI
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection modelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.51999-09-0158OAAI
Role of Simkania negevensis strain Z in respiratory disease in children in BrooklynPEDIATRIC RESEARCHIF3.11999-04-010OAAI